Vijaya Diagnostic Centre Ltd.

View in App
628.20 -9.55 ▼-1.5%

01 December 2023, 04:01:00 PM
Volume: 5,107

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.vijayadiagnostic.com
Market Cap 6,411.68 Cr.
Enterprise Value(EV) 6,308.71 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 10.11 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) 62.02 Trailing Twelve Months Ending 2023-09
Industry PE 63.34 Trailing Twelve Months Ending 2023-09
Book Value / Share 58.37 Trailing Twelve Months Ending 2023-09
Price to Book Value 10.74 Calculated using Price: 626.70
Dividend Yield 0.16 Period Ending 2023-03
No. of Shares Subscribed 10.23 Cr. 102,308,639 Shares
FaceValue 1
About Vijaya Diagnostic Centre Ltd.
The company is one of the fastest-growing diagnostic chains in Southern India. It offers a one-stop solution for pathology and radiology testing services.

Vijaya Diagnostic Centre Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Vijaya Diagnostic Centre Ltd. Performance

View details >>
1 Day
-1.50%
1 Week
+7.73%
1 Month
+8.83%
3 Month
+22.67%
6 Month
+62.98%
1 Year
+27.93%
2 Year
+8.96%
5 Year
10 Year

Vijaya Diagnostic Centre Ltd. Fundamental Ratios

View details >>
5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 22.58 26.07 26.91 26.85 16.89
Return on Capital Employed (%) 31.56 35.47 37.97 39.37 26.53
Return on Assets (%) 11.42 14.11 16.76 17.85 11.00

Vijaya Diagnostic Centre Ltd. Balance Sheet

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 207 275 359 468 545 597
Non Curr. Liab. 141 148 132 169 232 244
Curr. Liab. 57 59 44 66 66 79
Minority Int. 0 0 0 1 2 2
Equity & Liab. 405 481 535 705 845 922
Non Curr. Assets 268 294 296 435 570 604
Curr. Assets 137 186 239 270 276 319
Misc. Exp. not W/O
Total Assets 405 481 535 705 845 922

Vijaya Diagnostic Centre Ltd. Profit and Loss

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 293 339 377 462 459 494
Other Income 10 15 12 13 14 21
Total Income 303 354 389 475 473 515
Total Expenditure -184 -206 -211 -259 -277 -295
PBIDT 118 148 178 217 196 219
Interest -14 -15 -15 -16 -21 -23
Depreciation -40 -49 -50 -53 -62 -58
Taxation -19 -21 -27 -37 -28 -34
Exceptional Items
PAT 46 63 85 111 85 104
Minority Interest -1 -1 -1 -1
Share Associate
Other Related Items
Consolidated Net Profit 46 63 84 110 85 103
Adjusted EPS 5 6 8 11 8 10

Vijaya Diagnostic Centre Ltd. Cash Flow

View details >>
Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 91 106 130 158 165
Cash Fr. Inv. -90 -31 -130 -123 -110
Cash Fr. Finan. -7 -30 -49 -31 -42
Net Change -7 46 -49 4 13
Cash & Cash Eqvt 10 56 7 11 24

Vijaya Diagnostic Centre Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 54.78 54.78 54.78 55.04 55.01 55.01 55.01 54.98 54.90
Public 45.22 45.22 45.22 44.96 44.99 44.99 44.99 45.02 45.10
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Vijaya Diagnostic Centre Ltd. Announcements

View details >>
Thu, 16 Nov 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings Call Transcript for the Q2 FY24 Call held on Nov 8 2023
Wed, 08 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find attached Newspaper advertisement regarding the Unaudited Financial Results of the Company for the quarter and half year ended September 30 2023
Wed, 08 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
We are providing hereunder the Link to access the Audio Recording of Earnings Conference Call organized on November 08 2023 post declaration of the Unaudited Financial Results of the Company for the second quarter and half year ended September 30 2023 for your information and records.https://images.vijayadiagnostic.com/investor/FinancialResults/Earnings+Call+Audio+-+Q2+FY24.mp3 (Click here)Please take the information on record.

Vijaya Diagnostic Centre Ltd. Technical Scans

View details >>
Fri, 01 Dec 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Vijaya Diagnostic Centre Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 295,418.12 1,231.25 +0.4%
Divi's Laboratories Ltd. 100,674.98 3,792.70 +0.1%
Cipla Ltd. 97,418.94 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. 95,866.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. 80,322.42 5,570.00 +0.7%
Mankind Pharma Ltd. 76,800.82 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. 72,809.77 2,151.30 +1.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.56 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 75.59 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 28.21 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.83 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 115.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 59.91 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 54.58 2,151.30 +1.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.94 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.94 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-09 3.92 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.76 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.36 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.11 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.86 2,151.30 +1.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,151.30 +1.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,151.30 +1.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,231.25 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,792.70 +0.1%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,749.40 -0.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,570.00 +0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,914.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,151.30 +1.1%

Vijaya Diagnostic Centre Ltd. FAQ's

What is Vijaya Diagnostic share price?
Can I buy Vijaya Diagnostic shares now?
What is the Dividend Yield of Vijaya Diagnostic?
What is the Market Cap of Vijaya Diagnostic?
What are the key metrics to analyse Vijaya Diagnostic?
What is the 52 Week High and Low of Vijaya Diagnostic?
What is the trend of Vijaya Diagnostic share price?